RT Journal Article
SR Electronic
T1 Violin plot data: A concerto of crucial information on valve thrombogenicity classified using laboratory measured valve motion
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19009407
DO 10.1101/19009407
A1 Lawrence N. Scotten
A1 David Blundon
A1 Marcus-André Deutsch
A1 Rolland Siegel
YR 2020
UL http://medrxiv.org/content/early/2020/02/10/19009407.abstract
AB Objectives This in vitro study compares mechanical (MHV) and bioprosthetic (BHV) heart valves for high amplitude short duration regional flow velocities (RFV) near valve closure.Background We previously tested several clinical and prototype valves and observed RFV at levels which may be related to a dimensionless thrombogenic potential (TP).Methods A total of four valves were tested in aortic and mitral sites under pulsatile circulation in a pulse duplicator. Valves included both clinical models and experimental prototypes. An optical approach measuring projected dynamic valve area (PDVA) to gauge valve motion was implemented. Pulsatile pressures and flow rates were measured by conventional techniques and a quasi-steady flow tester was used to measure valve leakage. RFV was derived using time-dependent volumetric flow rate/PDVA. Since flow velocity and fluid shear force are related through flow velocity gradient, TPs for valves that achieve near closure during the forward flow deceleration phase were determined as RFVs relative to the control mechanical valve RFV value of −126 m/s.Results TP is dimensionless and ranged between −0.45 and +1.0. Negative TPs arise when transient rebound of valve occluders is accompanied by water-hammer phenomena. Positive TPs occur during decelerating forward flow. Bioprostheses had lowest TP transient of 0.15. A mock-transcatheter aortic valve (mTAVI) incorporating by design a trivial perivalvular leak (∼1.35 ml/s). demonstrated a high transient TP of 0.95.Conclusions Our data reveals distinct TP profile differences between valve models. If verifiable, the design of future valves may utilize currently available experimental tools to determine TPs resulting in advanced devices with significantly reduced TP.Ultramini-Abstract This in vitro study compares mechanical (MHV) and bioprosthetic (BHV) heart valves for high amplitude short duration inferred regional flow velocities (RFV) near valve closure.Background We previously tested several clinical and prototype valves and observed regional flow velocities (RFV) at levels which may be related to a dimensionless thrombogenic potential (TP).Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis research has been done on a pro bono basis by all authors with no financial support of others.Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableAll data relevant to the study are included in the article or uploaded as supplementary information.